Various changing factors in the US have resulted in the new availability of generic drug formulations.

Patients, prescribers, pharmacists and generic manufacturers all stand to gain from these initiatives.

On 21 June, new FDA commissioner Scott Gottlieb announced (in FDA Voice) said: "Too many patients are being priced out of the medicines they need. While FDA doesn’t have a direct role in drug pricing, we can take steps to help address this problem by facilitating increased competition in the market for prescription drugs through the approval of lower-cost, generic medicines."

Click the link to learn more.